This announcement is a separate document:
泰林生物：上海锦天城（杭州）律师事务所关于浙江泰林生物技术股份有限公司2022年限制性股票激励计划首次授予部分第一个归属期归属条件成就、作废2022年限制性股票激励计划部分已授予尚未归属的限制性股票的法律意见书
Tailin Biology: Legal opinion from Shanghai Jintiancheng (Hangzhou) Law Firm on Zhejiang Tailin Biotechnology Co., Ltd.\'s 2022 restricted stock incentive plan granted some of the first vesting conditions for the first vesting period, and the annulment of
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.